ARCT SG&A Expense Growth
Arcturus Therapeutics Holdings Inc · SG&A Expense Growth
ARCT SG&A Expense Growth
Latest reported-12.77%period ending
ARCT FY SG&A Growth (YoY) (0.00% → -12.77%)
Latest values, visible window
High-resolution chart · PNG
ARCT sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -12.7672% | |
| -0.0908% | |
| 14.7598% | |
| 11.1457% | |
| 65.0317% | |
| 98.3652% | |
| -38.4802% | |
| 171.8172% | |
| 41.3478% | |
| 7.3117% | |
| -14.5059% | |
| 81.1104% | |
| 372.0351% | |
| -67.2265% | |
| 0% |